These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 22978440)
1. The effect of metformin and thiazolidinedione use on lung cancer in diabetics. Mazzone PJ; Rai H; Beukemann M; Xu M; Jain A; Sasidhar M BMC Cancer; 2012 Sep; 12():410. PubMed ID: 22978440 [TBL] [Abstract][Full Text] [Related]
2. Effectiveness and long-term safety of thiazolidinediones and metformin in renal transplant recipients. Kurian B; Joshi R; Helmuth A Endocr Pract; 2008 Nov; 14(8):979-84. PubMed ID: 19095596 [TBL] [Abstract][Full Text] [Related]
3. Metformin and thiazolidinediones are associated with improved breast cancer-specific survival of diabetic women with HER2+ breast cancer. He X; Esteva FJ; Ensor J; Hortobagyi GN; Lee MH; Yeung SC Ann Oncol; 2012 Jul; 23(7):1771-80. PubMed ID: 22112968 [TBL] [Abstract][Full Text] [Related]
4. Dose effect of thiazolidinedione on cancer risk in type 2 diabetes mellitus patients: a six-year population-based cohort study. Lin HC; Hsu YT; Kachingwe BH; Hsu CY; Uang YS; Wang LH J Clin Pharm Ther; 2014 Aug; 39(4):354-60. PubMed ID: 24661226 [TBL] [Abstract][Full Text] [Related]
5. Intensification with dipeptidyl peptidase-4 inhibitor, insulin, or thiazolidinediones and risks of all-cause mortality, cardiovascular diseases, and severe hypoglycemia in patients on metformin-sulfonylurea dual therapy: A retrospective cohort study. Wong CKH; Man KKC; Shi M; Chan EW; Ho CW; Tse ETY; Wong ICK; Lam CLK PLoS Med; 2019 Dec; 16(12):e1002999. PubMed ID: 31877127 [TBL] [Abstract][Full Text] [Related]
6. Important differences in the durability of glycaemic response among second-line treatment options when added to metformin in type 2 diabetes: a retrospective cohort study. Mamza J; Mehta R; Donnelly R; Idris I Ann Med; 2016; 48(4):224-34. PubMed ID: 26982210 [TBL] [Abstract][Full Text] [Related]
7. Thiazolidinediones and metformin associated with improved survival of diabetic prostate cancer patients. He XX; Tu SM; Lee MH; Yeung SJ Ann Oncol; 2011 Dec; 22(12):2640-2645. PubMed ID: 21415239 [TBL] [Abstract][Full Text] [Related]
8. Thiazolidinedione addition reduces the serum retinol-binding protein 4 in type 2 diabetic patients treated with metformin and sulfonylurea. Lin KD; Chang YH; Wang CL; Yang YH; Hsiao PJ; Li TH; Shin SJ Transl Res; 2008 Jun; 151(6):309-14. PubMed ID: 18514142 [TBL] [Abstract][Full Text] [Related]
9. Progression to insulin for patients with diabetes mellitus on dual oral antidiabetic therapy using the US Department of Defense Database. Rascati K; Richards K; Lopez D; Cheng LI; Wilson J Diabetes Obes Metab; 2013 Oct; 15(10):901-5. PubMed ID: 23531154 [TBL] [Abstract][Full Text] [Related]
10. Effect of diabetes mellitus and metformin use on oncologic outcomes of patients treated with radical cystectomy for urothelial carcinoma. Rieken M; Xylinas E; Kluth L; Crivelli JJ; Chrystal J; Faison T; Lotan Y; Karakiewicz PI; Sun M; Fajkovic H; Babjuk M; Bachmann A; Scherr DS; Shariat SF Urol Oncol; 2014 Jan; 32(1):49.e7-14. PubMed ID: 24140245 [TBL] [Abstract][Full Text] [Related]
11. No reduced risk of overall, colorectal, lung, breast, and prostate cancer with metformin therapy in diabetic patients: database analyses from Germany and the UK. Kowall B; Stang A; Rathmann W; Kostev K Pharmacoepidemiol Drug Saf; 2015 Aug; 24(8):865-74. PubMed ID: 26132313 [TBL] [Abstract][Full Text] [Related]
12. Medicaid managed care: disparities in the use of thiazolidinediones compared with metformin. Shaya FT; Shin JY; Mullins D; Fatodu HO; Gu A; Saunders E J Natl Med Assoc; 2005 Apr; 97(4):493-7. PubMed ID: 15868769 [TBL] [Abstract][Full Text] [Related]
13. Metformin does not alter the risk of lung cancer: a case-control analysis. Bodmer M; Becker C; Jick SS; Meier CR Lung Cancer; 2012 Nov; 78(2):133-7. PubMed ID: 22959242 [TBL] [Abstract][Full Text] [Related]
14. Anti-diabetic medications do not influence risk of lung cancer in patients with diabetes mellitus: a systematic review and meta-analysis. Nie SP; Chen H; Zhuang MQ; Lu M Asian Pac J Cancer Prev; 2014; 15(16):6863-9. PubMed ID: 25169538 [TBL] [Abstract][Full Text] [Related]
15. A population-based cohort study in Taiwan--use of insulin sensitizers can decrease cancer risk in diabetic patients? Kao CH; Sun LM; Chen PC; Lin MC; Liang JA; Muo CH; Chang SN; Sung FC Ann Oncol; 2013 Feb; 24(2):523-530. PubMed ID: 23110810 [TBL] [Abstract][Full Text] [Related]
16. Cancer risks in thiazolidinedione users compared to other anti-diabetic agents. Koro C; Barrett S; Qizilbash N Pharmacoepidemiol Drug Saf; 2007 May; 16(5):485-92. PubMed ID: 17192841 [TBL] [Abstract][Full Text] [Related]
17. Metformin use and its effect on survival in diabetic patients with advanced non-small cell lung cancer. Arrieta O; Varela-Santoyo E; Soto-Perez-de-Celis E; Sánchez-Reyes R; De la Torre-Vallejo M; Muñiz-Hernández S; Cardona AF BMC Cancer; 2016 Aug; 16():633. PubMed ID: 27519177 [TBL] [Abstract][Full Text] [Related]
18. Progression to insulin for patients with diabetes mellitus using the Texas Medicaid database. Rascati KL; Richards KM; Lopez D; Cheng LI; Wilson JP Clin Ther; 2011 Dec; 33(12):2016-20. PubMed ID: 22101160 [TBL] [Abstract][Full Text] [Related]
19. Adherence to a fixed-dose combination of rosiglitazone maleate/metformin hydrochloride in subjects with type 2 diabetes mellitus: a retrospective database analysis. Vanderpoel DR; Hussein MA; Watson-Heidari T; Perry A Clin Ther; 2004 Dec; 26(12):2066-75. PubMed ID: 15823770 [TBL] [Abstract][Full Text] [Related]
20. Thiazolidinediones, metformin, and outcomes in older patients with diabetes and heart failure: an observational study. Masoudi FA; Inzucchi SE; Wang Y; Havranek EP; Foody JM; Krumholz HM Circulation; 2005 Feb; 111(5):583-90. PubMed ID: 15699279 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]